RR

Radha Rawat

Active Director Director DIN 10677949
DIN 10677949 First appointment Jun 2024 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2024
Shareholding value •••• Premium profile

About Radha Rawat

Data last updated:

Radha Rawat is a Director at Radmex Healthcare Private Limited (since 2024). The company operates in Pharma. Radmex Healthcare Private Limited reported revenue of ₹1.11 Cr (FY 2025).

DIN 10677949
Primary Designation Director
Industry Pharma
First Appointment 24 Jun 2024
Oldest Company Age 3 yrs
Largest company Radmex Healthcare Private Limited · ₹1.11 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Radmex Healthcare Private Limited U46497DL2023PTC415038
Director24 Jun 20242023₹1.11 Cr (FY 2025)Active

Board colleagues of Radha Rawat

Directorship timeline

Open interactive timeline →
Radmex Healthcare Private Limited
Premium access

Shareholding and investment profile for Radha Rawat

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Radha Rawat

Radha Rawat currently holds 1 directorship: Radmex Healthcare Private Limited (Director, since 24 Jun 2024, revenue ₹1.11 Cr (FY 2025)).

Radha Rawat was first appointed on 24 Jun 2024 as Director at Radmex Healthcare Private Limited.

The current boards of Radha Rawat's companies include Jaskabir Singh (Radmex Healthcare Private Limited), Monika (Radmex Healthcare Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available